We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Fast, Cost-Effective Technique Developed for Finding Gene "On-Off” Switches

By LabMedica International staff writers
Posted on 08 Jun 2009
Print article
Scientists have created a tool for rapidly identifying large numbers of the genetic material known as short hairpin RNA (shRNA) that turns genes on and off.

The method, which the research team has used to create a library of 22,000 of these "on-off” switches for approximately 600 human genes, provides a tool for scientists worldwide, with ultimate impacts on the study of the genetic basis of diseases ranging from HIV to high cholesterol, Parkinson's disease, or cancer. The scientists, from the University of California, San Francisco (UCSF; USA), are currently working on creating an shRNA library for the entire human genome. Findings are available in the advanced online publication section of the journal Nature Methods in May 2009 and will appear later in the print issue of the journal.

Since their discovery in the past 10 years, biologically active small RNAs have become the holy grail of much pharmaceutical and genomics research, offering the potential of creating targeted therapeutics to "turn off” or turn down the "volume” of various genes involved in disease, according to Michael McManus, Ph.D., a UCSF microbiology professor and senior author on the study. This process is known as RNA interference.

Until now, however, the process of finding shRNAs that are able to potently deactivate a given gene has been extremely labor-intensive and laden with many false results. The new method uses a microarray technology to generate large numbers of these shRNA strands for each target gene--approximately 10 times the volume of traditional methods--thereby enabling researchers to screen for RNA interference much faster than before and at a minimal cost, according to Dr. McManus. "This means that even a small laboratory with limited resources can perform complex genetic screens on mammalian cell cultures,” he said. "With the current scarcity of research funding, these are invaluable tools for researchers worldwide.”

Many diseases already have been linked to specific genes that are mutated or turned on to cause the illness. How those genes actually cause the illness is less clear, but by using shRNA to turn the genes off, researchers can study specific genetic function and start to identify drugs or therapeutics to change it. The system, which uses deep sequencing technology to rapidly uncover effective shRNAs by simultaneously sequencing millions of base pairs of DNA, also enables scientists to better identify which of those tiny RNA-strands is most effective in turning off a particular gene and which ones are effective but also cause side effects on untargeted genes.

Research into gene function has been done for years with worms and fruit flies, whose short life spans and rapid reproduction make genetic testing relatively inexpensive, Dr. McManus reported. But in mammals, studying the function of individual genes can often cost a laboratory US$100,000 or more in basic materials and require complex technology to run.

The UCSF shRNA library aims to offer more than 600,000 different samples of shRNA-- about 30 for every human gene. Once the shRNA library is complete for the human genome, the team will continue creating libraries for other species.

According to Dr. McManus, he plans to make shRNA libraries available through the UCSF Sandler Lentiviral RNAi Core, which he directs. The Core provides essential equipment, training, supervision, and monitoring for researchers working in lentiviral-based research, as well as offering viral packaging and other services for researchers.

Related Links:

University of California, San Francisco




Gold Member
Troponin T QC
Troponin T Quality Control
Automated Blood Typing System
IH-500 NEXT
New
Cortisol Rapid Test
Finecare Cortisol Rapid Quantitative Test
New
Progesterone Serum Assay
Progesterone ELISA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The AI program analyzes a microscopy image from a tumor biopsy and determines what genes are likely turned on and off in the cells it contains (Photo courtesy of Olivier Gevaert/Stanford Medicine)

AI Tool ‘Sees’ Cancer Gene Signatures in Biopsy Images

To assess the type and severity of cancer, pathologists typically examine thin slices of a tumor biopsy under a microscope. However, to understand the genomic alterations driving the tumor's growth, scientists... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.